[1]
Dewiputri, S. and Sidik, M. 2017. Clinical Outcome of Intravenous Glucocorticoid and Rituximab in Moderate to Severe Thyroid Eye Disease. Ophthalmologica Indonesiana. 42, 2 (Feb. 2017). DOI:https://doi.org/10.35749/journal.v42i2.82.